Golden State Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Golden State Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-350	Closed	-$45K	–	258
2020 Q1	$45K	Buy	+350	New	+$47.1K	0.02%	375
2019 Q4	–	Sell	-350	Closed	-$41K	–	129
2019 Q3	$41K	Sell	350 -75	-18%	-$9.33K	0.01%	468
2019 Q2	$54K	Hold	425	–	–	0.02%	438
2019 Q1	$55K	Buy	+425	New	+$53.7K	0.02%	415

Other funds holding BBH

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Golden State Wealth Management's BBH Position: Q2 2020 in Review

Golden State Wealth Management sold out of VanEck Biotech ETF (BBH) in Q2 2020, closing a stake of 350 shares — an estimated $45K sold.

Golden State Wealth Management first reported a position in BBH in Q1 2019 and held it in 4 quarters. The position peaked at $55K in Q1 2019. 102 funds tracked by Wall St. Rank hold BBH as of Q2 2020.

Golden State Wealth Management reported no remaining VanEck Biotech ETF position as of Q2 2020 after selling out during the quarter.
Golden State Wealth Management sold 350 VanEck Biotech ETF shares in Q2 2020, an estimated $45K.
Golden State Wealth Management first reported a position in VanEck Biotech ETF in Q1 2019 and held it in 4 quarters.
Golden State Wealth Management's VanEck Biotech ETF position peaked at $55K in Q1 2019.
102 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2020.

Based on Golden State Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.